Advertisement

Bladder Cancer | Tumor

CURE’s bladder cancer page is a go-to resource for oncology news and updates in the world of bladder cancer. Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in bladder cancer.

FDA Oncology Approval From Spring 2023

June 19th 2023

Here’s an overview of the new cancer regimens that gained Food and Drug Administration (FDA) approval in the spring of this year.

Acupuncture Reduced Bladder Cancer Pain, Urinary Symptoms

June 4th 2023

Acupuncture reduced pain “in a very significant way” and urinary symptoms for patients with non-muscle invasive bladder cancer who were undergoing BCG therapy.

Padcev Plus Keytruda Is ‘Exciting’ for Chemo-Ineligible Bladder Cancer

May 10th 2023

The recent FDA approval of Padcev plus Keytruda for locally advanced/metastatic, chemotherapy-ineligible bladder cancer offers an “exciting opportunity” for this difficult-to-treat patient population, an expert said.

When Things Go Wrong With Cancer Treatments

April 11th 2023

I developed tuberculosis — a rare but dangerous effect of certain bladder cancer treatments.

FDA Approves Padcev-Keytruda Combo for Advanced Bladder Cancer

April 3rd 2023

The FDA approved the combination for patients with locally advanced or metastatic urothelial carcinoma who are ineligible for treatment with cisplatin-based chemotherapy.

Enhertu Provides Meaningful, Durable Responses in HER2-Expressing Solid Tumors

March 14th 2023

The phase 2 DESTINY-PanTumor02 trial included patients with HER2-expressing solid tumors such as bladder, pancreatic and rare tumors.

Answering the Call for Bladder Cancer Support

March 7th 2023

Bladder cancer survivors face a bevy of challenges post-treatment, but an immediately available service strives to ease the burden.

Women May Experience Worse Quality of Life Than Men After Bladder Cancer Surgery

February 22nd 2023

Important data may encourage gender-specific treatment making decisions for patients with bladder cancer.

Survival Is Not Improved by Adding Tecentriq to Chemo for Metastatic Bladder Cancer

February 20th 2023

The addition of Tecentriq to platinum-based chemotherapy/gemcitabine did not boost outcomes in patients with metastatic bladder cancer, according to results from the IMvigor 140 trial.

Biomarkers May Predict Outcomes With Padcev to Treat Bladder Cancer Subtype

February 19th 2023

Researchers identified several biomarkers that may indicate how a patient responds to Padcev, a type of antibody drug conjugate for patients with urothelial carcinoma, a type of bladder cancer.

Padcev to Be Studied in Advanced Bladder Cancer

February 17th 2023

A clinical trial just kicked off, analyzing Padcev in patients with advanced, unresectable bladder cancer.

Tumor DNA May Predict Outcomes to Presurgical Treatment in Patients with Bladder Cancer

February 8th 2023

Data suggests an association between tumor DNA circulating in plasma and patient responses to neoadjuvant treatment.

White House Provides Cancer Moonshot Updates, Mets Broadcaster Reveals Cancer Diagnosis and More

February 3rd 2023

From funding updates on the Cancer Moonshot to Howie Rose’s bladder cancer diagnosis and more, here’s what’s happening in the oncology space this week.

Direct-to-Bladder Immunotherapy Drug to Be Studied in Bladder Cancer

February 1st 2023

The first patient was dosed with lerapolturev in a phase 1/2 clinical trial evaluating the drug in patients with bladder cancer and other solid tumors.

Cancer Is Like a Race, and I’m Determined to Win

January 25th 2023

Cancer — and its treatments — can feel like a grueling race, but I’m using frequent follow-ups and an excellent care team to stay ahead of the game.

FDA Is Speeding Up Review of Padcev-Keytruda Combo for Bladder Cancer

January 17th 2023

The Food and Drug Administration is speeding up the review and potential approval of Padcev plus Keytruda for certain patients with urothelial carcinoma, the most common form of bladder cancer.

Smoking May Double Risk for Recurrence in Some Patients With Bladder Cancer

January 2nd 2023

Patients with non-muscle invasive bladder cancer who currently smoke or previously smoked should consider quitting to possibly improve health outcomes in survivorship, according to an expert.

FDA Approves First Gene Therapy for Non-Muscle Invasive Bladder Cancer

December 16th 2022

Adstiladrin represents the first gene therapy approved by the FDA for the treatment of patients with high-risk non-muscle invasive bladder cancer who are resistant to BCG, the first-line standard of care for these patients.

Smoking History and Habits May Increase Bladder Cancer Recurrence Risk, Study Finds

December 15th 2022

Patients with non-muscle invasive bladder cancer who smoke should consider quitting to possibly improve health outcomes in survivorship, according to an expert.

Type of Surgery for Bladder Cancer May Impact Sexual Function

December 14th 2022

Sexual dysfunction is not less common in women with bladder cancer who undergo reproductive organ-sparing radical cystectomy, although more research is needed.

Even a 'Tough Guy' Can Open Up About Cancer

December 12th 2022

Men often decide to tough out their cancer alone, but tough guy Terry Bradshaw is starting to open up about his sometimes-rocky journey with the disease.

Cancer Survivor Throws Out World Series First Pitch, Dwayne ‘The Rock’ Johnson Sends Best Wishes to Child With Brain Cancer and More

November 4th 2022

From a childhood cancer survivor throwing out the first pitch at Game 4 of the World Series to former WWE champion and actor Dwayne “The Rock” Johnson recording a message for a child with brain cancer, here’s what’s happening in the cancer space this week.

End-of-Life Discussions Can ‘Lay Out a Roadmap’ of Patient Wishes and Avoid Unnecessary Cancer Care

November 2nd 2022

Talking about the end of life can be difficult, but these conversations are crucial for patients with incurable cancer to have with their clinicians, experts say.

Standup Comedian and Self-Proclaimed 'Love Goddess' Judy Tenuta Dies From Cancer, New England Patriots Host a ‘Day of Pampering’ for Cancer Survivors and More

October 7th 2022

From the death of standup comedian and "Love Goddess" Judy Tenuta to professional sports hall-of-famers discussing their cancer, here’s what’s happening in the cancer space this week.

Living Well Beyond Bladder Cancer With Support

September 29th 2022

As part of its “Speaking Out” video series, CURE spoke with Dr. Tracy L. Rose, on behalf of the Bladder Cancer Advocacy Network, about support available for patients and caregivers following a bladder cancer diagnosis.

Expert Discusses Effects of a Bladder Cancer Diagnosis on Caregivers and the Support Available to Them

September 29th 2022

As part of its “Speaking Out” video series, CURE spoke with Dr. Tracy L. Rose, on behalf of the Bladder Cancer Advocacy Network, about the role of the caregiver in bladder cancer and how they can also seek support to aid them.

Patients Can Help Move the Needle Forward in Bladder Cancer Clinical Trials With Participation

September 29th 2022

As part of its “Speaking Out” video series, CURE spoke with Dr. Tracy L. Rose, on behalf of the Bladder Cancer Advocacy Network, about how patients can find clinical trials they may be eligible for.

Having Open and Honest Conversations With Oncologists Aids in Patient-Physician Communication in Bladder Cancer

September 29th 2022

As part of its “Speaking Out” video series, CURE spoke with Dr. Tracy L. Rose, on behalf of the Bladder Cancer Advocacy Network, about letting physicians know about patient preferences to improve communication and select the right treatment option.

Combining Old and New Therapies in Advanced Bladder Cancer Shows Promise for the Future

September 29th 2022

As part of its “Speaking Out” video series, CURE spoke with Dr. Tracy L. Rose, on behalf of the Bladder Cancer Advocacy Network, about how currently available agents are being investigated in combination with one another.

Chemoradiotherapy May Provide Long-Term Survival Benefit for Muscle-Invasive Bladder Cancer

September 19th 2022

Long-term outcomes from this trial confirm the benefit of treatment with chemoradiotherapy over chemotherapy alone for patients with muscle-invasive bladder cancer.

NEXT PAGE
PREVIOUS PAGE
Advertisement
Advertisement